UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549 

 

FORM 8-K

 

CURRENT REPORT 

Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): September 4, 2019                         

 

               Creative Medical Technology Holdings, Inc.                

(Exact name of registrant as specified in its charter)

 

Nevada   000-53500   88-0622284
(State or other jurisdiction   (Commission File Number)   (I.R.S. Employer
of incorporation)       Identification Number)

 

            2008 W Lupine Ave, Phoenix, AZ 85029            

(Address of principal executive offices)

 

             (602) 680-7439            

(Registrant’s telephone number, including area code)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

o Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading
Symbol(s)
  Name of each exchange on which registered
N/A   N/A   N/A

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).

Emerging growth company o

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. o 

 

 

 

 

 

Item 8.01. Other Events.

 

On September 4, 2019, Creative Medical Technology Holdings, Inc. issued the press release furnished as Exhibit 99.1 to this Form 8-K.

 

Item 9.01. Financial Statements and Exhibits.

 

(d)       Exhibits.

 

Exhibit 99.1 Press Release dated September 4, 2019.

 

 

SIGNATURES

 

 

Pursuant to the requirements of the Securities and Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


 

  Creative Medical Technology Holdings, Inc.
 
   
Date: September 9, 2019 By: /s/ Timothy Warbington
  Timothy Warbington, Chief Executive Officer

 

 

 

Creative Medical Technol... (PK) (USOTC:CELZ)
Historical Stock Chart
From Nov 2020 to Dec 2020 Click Here for more Creative Medical Technol... (PK) Charts.
Creative Medical Technol... (PK) (USOTC:CELZ)
Historical Stock Chart
From Dec 2019 to Dec 2020 Click Here for more Creative Medical Technol... (PK) Charts.